TecDAX
Lumentum Shares Slip After Convertible Bond Swap, But Record Guidance and Nvidia’s $2B Bet Keep Bulls in Charge
The optics specialist punched out one of its best quarters ever, yet the stock took a modest hit Friday following...
Ams Osram’s June Agenda: A €570M Sensor Sale, Board Refresh, and a High-Stakes Bet on AI Photonics
The Austrian chipmaker ams OSRAM has two pivotal June milestones converging: the closure of its €570 million non-optics sensor sale...
Ams Osram’s June AGM Shreds an Obsolete Capital Cushion as Divestiture Engine Revs
When Ams Osram shareholders gather in Premstätten on 10 June, they will be asked to approve more than just routine...
AMD’s Trans-Pacific Capacity Race: $7B Arizona Bet Meets Taiwan’s 2nm Surge
Advanced Micro Devices is pursuing a dual-geography strategy to secure the packaging and fabrication capacity needed to feed its surging...
BioNTech’s $650 Million R&D Quarter: Shareholders Back Board Expansion as Market Awaits Lung Cancer Data
Despite sitting on nearly $20 billion in cash, BioNTech is burning through money at an accelerating pace as it races...
Kontron’s Defense Boom Masks a Cash Drain That Only a Sale Can Fix
Kontron’s third quarter will be the moment of truth. That is when a planned €126 million injection from a division...
BioNTech’s Radical Overhaul: 1,860 Job Cuts, Factory Shutdowns, and a €532 Million Loss as Cancer Bet Takes Center Stage
The era of pandemic-era blockbuster revenues at BioNTech has come to a definitive end. The Mainz-based biotech is shuttering four...
Kontron’s Record Order Book Masks the Cost of a Painful Restructuring
Kontron’s first-quarter results present a study in contrasts. On the surface, the numbers look underwhelming: net profit nearly halved and...
Broadcom’s AI Chip Empire Tightens as Golden Cross Signals More Upside
The stars are aligning for Broadcom. The chipmaker has locked in a trio of marquee AI clients within a single...
BioNTech’s May Gauntlet: Earnings, a Shareholder Vote, and an Insider Sale Set the Stage
The first half of May is shaping up as a critical inflection point for BioNTech, with the German biotech facing...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
